Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting

Abstract Background Idarucizumab is a specific reversal agent for dabigatran, a direct oral anticoagulant. In 2015, idarucizumab was approved in Europe to quickly restore coagulation and it is currently subject to additional safety monitoring. The drug is administered only during inpatient or emerge...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2020-11, Vol.41 (Supplement_2)
Hauptverfasser:	Lombardi, N, Brilli, V, Crescioli, G, Bettiol, A, Ippazio, C.A, Mazzaglia, G, Fumagalli, S, Mannaioni, G, Vannacci, A, Gini, R
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!